Aveo Pharmaceuticals (AVEO) 1.50 $AVEO Midday Gainers /

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aveo Pharmaceuticals (AVEO) 1.50 $AVEO

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 11:45AM CST

SSH: 4.03 (-1.32), ONCY: 0.90 (-0.15), LTM: 66.32 (+8.65), LEDS: 1.03 (-0.13), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), EXAS: 24.50 (+2.07), DRRX: 1.64 (+0.30), DRAD: 4.88 (+0.48), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), ICEL: 6.61 (+0.99), BORN: 1.23 (-0.32), DMD: 5.95 (+0.70), AVEO: 1.50 (+0.08), CALA: 14.67 (+1.36), MTL: 1.53 (-0.30), CKP: 11.37 (-2.06), ERII: 2.79 (-0.47)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 8:15AM CST

NGL: 27.04 (-1.94), FNSR: 22.23 (+1.90), SSH: 4.03 (-1.32), YY: 57.76 (+2.59), CNAT: 6.05 (-0.54), ASTI: 1.43 (-0.02), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), VMEM: 3.59 (-0.40), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), SKUL: 10.40 (-0.67), CALA: 14.67 (+1.36), AVEO: 1.50 (+0.08), MSO: 4.96 (+0.09), GALE: 1.88 (-0.12), CKP: 11.37 (-2.06)

AVEO Pharmaceuticals misses by $0.06
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 5:15AM CST

AVEO: 1.50 (+0.08)

Regulators Want Drug Companies to Be Honest About FDA
at The Street - Wed Mar 04, 12:08PM CST
The Securities and Exchange Commission's top cop wants drug companies to be more transparent with investors about their dealings with the U.S. Food and Drug Administration.
HEB: 0.25 (-0.01), AVEO: 1.50 (+0.08), AMPE: 5.88 (+0.02), SNY: 47.42 (-0.94)

Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 17.44 (+0.37), ABTL: 14.46 (-0.31), XIN: 3.11 (-0.08), AVEO: 1.50 (+0.08), TTI: 5.38 (-0.14), CLNE: 5.47 (-0.07)

Aveo Oncology to host conference call to discuss trial results
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:38AM CST

AVEO: 1.50 (+0.08)

Seeking Baupost: The Pangs Of Value Investing - Part 1
Matthew Finston - at Seeking Alpha - Mon Feb 16, 9:28AM CST

ELOS: 12.22 (+0.20), MU: 28.50 (-0.78), AR: 36.89 (-0.24), PBF: 29.59 (-1.10), OCN: 8.91 (+0.24), NCQ: 0.68 (-0.02), LNG: 76.91 (-1.50), KOS: 8.28 (+0.01), KIN: 6.68 (-0.20), VSAT: 64.50 (-0.25), KERX: 12.56 (-0.63), NG: 3.26 (-0.19), BXE: 2.99 (-0.06), AOI: 0.95 (-0.03), EBAY: 59.87 (+0.79), ALDW: 19.04 (-0.06), BYD: 13.92 (-0.04), AVEO: 1.50 (+0.08), SEMI: 24.40 (+0.49), VRTV: 50.05 (-0.17), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), IMOS: 23.28 (-0.27)

CAR-T Vs ErbB3 Market Opportunity Comparison
Decision Analytics - Seeking Alpha - Wed Jan 21, 12:32PM CST
CAR-T therapy, also known as "Adoptive Immunotherapy", has been the result of significant investor excitement recently. One look at the stock charts for JUNO and KITE is illustrative of this optimism. While this enthusiasm may be warranted,...
MACK: 12.38 (-0.10), BLUE: 113.14 (+0.91), ZIOP: 13.38 (-0.43), BLCM: 24.48 (+0.13), KITE: 66.41 (+1.44), AVEO: 1.50 (+0.08), JUNO: 52.84 (+0.81), GSK: 46.73 (-0.87), REGN: 422.13 (-6.82), NVS: 97.46 (-1.49)

AVEO to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 12, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced that Michael P. Bailey, president and chief executive officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015 at 12:00PM (PT) in San Francisco.
JPM: 60.89 (-1.11), AVEO: 1.50 (+0.08)

New medical chief at Aveo
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 7:06AM CST

AVEO: 1.50 (+0.08)

AVEO Names Michael N. Needle, M.D., As Chief Medical Officer
Business Wire - Fri Jan 09, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced the appointment of Michael N. Needle, M.D., to the position of Chief Medical Officer. In this role, Dr. Needle, a board certified hematologist/oncologist, will take a leadership role in evaluating clinical development strategies for advancement of the Company's partnered and proprietary pipeline programs. He will report to Michael Bailey, AVEO's president and chief executive officer.
AVEO: 1.50 (+0.08)

AVEO Receives Confirmation of Eligibility for Submission of a Tivozanib Marketing Authorization Application to the European Medicines Agency
Business Wire - Thu Jan 08, 5:30AM CST
AVEO Oncology (NASDAQ:AVEO) today announced that it has received written confirmation from the European Medicine Agency (EMA) that tivozanib is eligible for submission of an application for a European Union Marketing Authorization under the Agency's centralized procedure. Confirmation of eligibility was given in response to the submission of a letter of intent enabling the Company to evaluate the opportunity for submitting a Marketing Authorization Application (MAA) for tivozanib with the EMA for the treatment of renal cell carcinoma (RCC). Tivozanib is an oral, potent, selective inhibitor of vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) with a long half-life and activity against all three VEGF receptors. Tivozanib has previously been granted orphan drug designation in Europe for the treatment of RCC.
AVEO: 1.50 (+0.08)

Aveo names new chief amid restructuring
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:19AM CST

AVEO: 1.50 (+0.08)

AVEO Announces Executive Transition and Corporate Restructuring
Business Wire - Wed Jan 07, 5:30AM CST
--Company to Eliminate Internal Research Function to Align Corporate Resources with the Company's Future Strategic Plans
AVEO: 1.50 (+0.08)

Aveo up on (old) news of Klarman stake
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 11:00AM CST

OPHT: 53.19 (-0.29), AVEO: 1.50 (+0.08)

The New Baupost Biotech Picks
Matthew Finston - at Seeking Alpha - Mon Dec 15, 8:53AM CST

BIIB: 417.63 (-7.98), FWP: 22.81 (-0.12), MRK: 56.84 (-1.14), AVEO: 1.50 (+0.08), IDIX: 24.50 (+0.05), ATRA: 28.31 (-0.44), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), PRTK: 31.54 (+1.73), KIN: 6.68 (-0.20), KERX: 12.56 (-0.63)

Tracking Seth Klarman's Baupost Group Holdings - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 9:14AM CST

OCN: 8.91 (+0.24), KOS: 8.28 (+0.01), KIN: 6.68 (-0.20), VSAT: 64.50 (-0.25), RFMD: 16.59 (-0.35), EBAY: 59.87 (+0.79), TQNT: 27.55 (-0.77), IDIX: 24.50 (+0.05), SEMI: 24.40 (+0.49), VRTV: 50.05 (-0.17), THRX: 19.60 (-0.26), TBPH: 20.23 (-0.52), IMOS: 23.28 (-0.27), ELOS: 12.22 (+0.20), MU: 28.50 (-0.78), AR: 36.89 (-0.24), NCQ: 0.68 (-0.02), PBF: 29.59 (-1.10), LNG: 76.91 (-1.50), ATRA: 28.31 (-0.44), KERX: 12.56 (-0.63), NG: 3.26 (-0.19), AOI: 0.95 (-0.03), FWP: 22.81 (-0.12), BYD: 13.92 (-0.04), ALDW: 19.04 (-0.06), SUNE: 22.64 (-0.53), MRK: 56.84 (-1.14), AVEO: 1.50 (+0.08), AIG: 56.00 (+0.39)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 125

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 41

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 35

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 92

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 201

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 114

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 146

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 175

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading

Top 5 Most Recently Viewed Articles

Brave Healer Productions Unveils Transformational Book Series

Updated Category News Views 253

Brave Healer Productions Unveils Transformational Book Series Brave Healer Productions has made an exciting announcement with the introduction of Shaman Heart: We Are the Ones We've Been Waiting For, the third volume in the acclaimed Shaman Heart series. This significant release highlights the wisdom of 26 courageous healers, teachers, and spiritual mentors who embarked...

Continue Reading
Empowering Fans: Miss Universe Adopts Blockchain Voting App

Updated Category News Views 314

Revolutionizing Fan Engagement with Blockchain Technology In a historical move that blends tradition with technology, the Miss Universe Organization (MUO) has partnered with Zetrix to unveil the Miss Universe Global Blockchain Voting App. This strategic alliance aims to empower fans worldwide by facilitating secure and trustworthy voting experiences, marking a significant...

Continue Reading
Occidental Bets Big on Argentine Sunflower Boom

Updated Category News Views 64

The Sunflower Seed Gamble When a company like Occidental Resources plunks down $200 million for sunflower seeds, you sit up and take notice. We're talking 300,000 metric tons of those little yellow gems sourced from Argentina, which according to the Rosario Board of Trade, is rolling in a whopping 6.6 million metric tons of sunflower product this year. Doesn't sound like...

Continue Reading
Martini Market’s $MRT Presale: Last Chance to Seize the Opportunity

Updated Category News Views 207

The Exciting Conclusion of the Martini Market Presale As the highly anticipated $MRT token presale approaches its final days, the excitement is palpable in the decentralized finance (DeFi) community. With just a few days left, Martini Market has established itself as a frontrunner in the realm of decentralized prediction markets on the XRP Ledger. What Makes Martini...

Continue Reading
Samsara Intelligence: Transforming Operations with AI Power

Updated Category News Views 345

Revolutionizing Operations with Samsara Intelligence Samsara Inc. (NYSE: IOT), a trailblazer in the Connected Operations Cloud space, has just launched Samsara Intelligence. This sophisticated suite of AI offerings is crafted to assist businesses in making informed decisions, thereby streamlining operations while ensuring safety. Harnessing an extensive database that...

Continue Reading